Background Nicotine receptor partial agonists may help people to stop smoking by a
combination of maintaining moderate levels of dopamine to counteract withdrawal …

Background Whilst the pharmacological profiles and mechanisms of antidepressants are
varied, there are common reasons why they might help people to stop smoking tobacco …

Background: Tobacco smoking is the leading cause of preventable death in the United
States, and the annual economic burden attributable to smoking exceeds US $300 billion …

Introduction: Women have lower rates of quitting than men with both bupropion and nicotine
replacement. It is unknown whether varenicline demonstrates differential efficacy for men …

Introduction Efficacious pharmacological interventions for smoking cessation are available,
but poor adherence to these treatments may limit these interventions overall impact. To …

Background Pharmacological treatments for tobacco dependence, such as nicotine
replacement therapy (NRT), have been shown to be safe and effective interventions for …

Aims To identify promising intervention components that help smokers attain and maintain
abstinence during a quit attempt. Design A 2× 2× 2× 2× 2 randomized factorial experiment …

Background and aim It is useful, for theoretical and practical reasons, to be able to specify
functions for continuous abstinence over time in smoking cessation attempts. This study …

Aims Lack of adherence to smoking cessation medication regimens is assumed to play a
significant role in limiting their effectiveness. This study aimed to assess evidence for this …

Introduction: Patient adherence to smoking cessation medications can impact their
effectiveness. It is important to understand the extent to which prescribed medications are …